Company: EUDAW
Filing Date: 2025-12-04
Form Type: 424B5
Source: 0001493152-25-026224
Chunk: 18

Company: EUDA Health Holdings Ltd
Filing Date: 2025-12-04
Form: 424B5
Chunk 18
---
 a weighted-average exercise price        
 of $1.42 per share.                                                                                                                  |
| ● | 4,458,625                                                                                                                            
 of our ordinary shares issuable upon exercise of an aggregate of 8,917,250 outstanding warrants at a weighted-average exercise price 
 of $11.50 per share.                                                                                                                 |

| S-12 |

<div align='center'>DIVIDEND POLICY</div>

We have never paid or declared any cash dividends on our ordinary shares. We currently intend to retain all available funds and any future earnings to fund the development and expansion of our business, and we do not anticipate paying any cash dividends in the foreseeable future.

| S-13 |

<div align='center'>DESCRIPTION OF SECURITIES WE ARE OFFERING</div>

Description of Warrant

The material terms and provisions of the Warrant being offered pursuant to this prospectus supplement and being issued to the Investor are summarized below. The Purchase Agreement and form of Warrant will be filed as exhibits to a Current Report on Form 6-K with the SEC in connection with this offering. The following summary of certain material terms and provisions of the Warrant does not purport to be a complete description of the Warrant, and is subject to the detailed provisions of, and qualified in its entirety by reference to, the Warrant.

Exercise of Warrant

Upon issuance, the Warrant will be immediately exercisable by the Investor into 2,000,000 newly-issued ordinary shares, no par value each, of the Company (the “Warrant Shares”) at an exercise price of $6.00 per share (the “Exercise Price”) for ninety (90) days from the issuance date (the “Cash Exercise Period”). The Cash Exercise Period may be extended by mutual agreement of the Company and the Investor. Exercise by the Investor shall be effectuated by submitting to Company (by delivery to Company or by email) a completed and signed Notice of Exercise. The Notice of Exercise shall be executed by Investor and shall indicate (i) the number of Warrant Shares to be issued pursuant to such exercise, and (ii) whether the exercise is a cashless exercise. A cashless exercise may only occur after the Cash Exercise Period has expired and after the Company has had the opportunity to repurchase any remaining portion of the then outstanding Warrant in cash for $0.0625 per Warrant Share (see “ Repurchase Period” and “ Cashless Exercise” below). Upon appropriate payment to the Company of the Exercise Price for the W